Concepedia

Friederike Stoll

FS

4

Publications

303

Citations

4

H-Index

2002

Active since

Affiliations

Bayer (Germany)(Current)

Heinrich Heine University Düsseldorf

Friederike Stoll is an author at Bayer (Germany) specializing in drug discovery, medicine, and pharmacology.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryUrologyChemistryNephrologyEngineeringDrug AnalysisPharmacotherapy

Publications per year

2002–2018

4

Publications

4

Binding Free Energy Calculations for Lead Optimization: Assessment of Their Accuracy in an Industrial Drug Design Context

Nadine Homeyer, Friederike Stoll, Alexander Hillisch et al. · Journal of Chemical Theory and Computation · 2014 · 172 citations

Pharmaceutical Research, Engineering, Chemical Analysis +19

Discovery of Molidustat (BAY 85‐3934): A Small‐Molecule Oral HIF‐Prolyl Hydroxylase (HIF‐PH) Inhibitor for the Treatment of Renal Anemia

Hartmut Beck, Mario Jeske, Kai Thede et al. · ChemMedChem · 2018 · 74 citations · Full text

Bay 85‐3934, Hif-ph Mimics Hypoxia, Pharmacotherapy +20

Identification of residues crucially involved in soluble guanylate cyclase activation

Christiane Rothkegel, Péter Schmidt, Friederike Stoll et al. · FEBS Letters · 2006 · 33 citations

Pharmacophore Definition and Three-Dimensional Quantitative Structure-Activity Relationship Study on Structurally Diverse Prostacyclin Receptor Agonists

Friederike Stoll, Sven Liesener, Thomas Hohlfeld et al. · Molecular Pharmacology · 2002 · 24 citations

Rows per page

1–4 of 4